Johnson & Johnson says it's delaying rollout of its coronavirus vaccine in Europe amid US probe into rare blood clots.
Johnson & Johnson says it's delaying rollout of its coronavirus vaccine in Europe amid US probe into rare blood clots.
ALSO READ
-
Middle Corridor Could Create 2 Million Jobs and Transform Trade in Nine Nations
-
Historic Move: U.S. Army Base in Poland Signals Stronger Alliance
-
Europe on the Brink: Slovak PM Advocates for Peace Amid Rising Tensions
-
Diplomatic Exclusion Raises Alarm in U.S. Military Review
-
Europe's Migration Crisis: Fewer Arrivals, More Fatalities
Google News